RIL
ZVRA icon

Rothschild Investment LLC’s Zevra Therapeutics ZVRA Stock Holding History

Rothschild Investment LLC’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28K Buy
229
+119
+108% +$1.32K ﹤0.01% 2515
2026
Q1 		$1.02K Buy
110
+55
+100% +$496 ﹤0.01% 2862
2025
Q4 		$493 Hold
55
– – ﹤0.01% 2927
2025
Q3 		$523 Sell
55
-35
-39% -$351 ﹤0.01% 2814
2025
Q2 		$793 Sell
90
-30
-25% -$243 ﹤0.01% 2577
2025
Q1 		$899 Buy
120
+35
+41% +$278 ﹤0.01% 2402
2024
Q4 		$709 Buy
85
+60
+240% +$512 ﹤0.01% 2398
2024
Q3 		$174 Hold
25
– – ﹤0.01% 2733
2024
Q2 		$123 Buy
+25
New +$118 ﹤0.01% 2666

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rothschild Investment LLC's ZVRA Position: Q2 2026 in Review

Rothschild Investment LLC increased its Zevra Therapeutics (ZVRA) stake by 108% in Q2 2026, buying an estimated $1.32K and bringing the position to 229 shares worth $3.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

Rothschild Investment LLC first reported a position in ZVRA in Q2 2024 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Rothschild Investment LLC held 229 shares of Zevra Therapeutics worth $3.28K as of Q2 2026.
  • Rothschild Investment LLC bought 119 Zevra Therapeutics shares in Q2 2026, an estimated $1.32K.
  • Zevra Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2515 holding.
  • Rothschild Investment LLC first reported a position in Zevra Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.